The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
27-Hydroxycholesterol Is an Endogenous Selective Estrogen Receptor Modulator
Open accessAbstract
Selective estrogen receptor (ER) modulators (SERMs) are ER ligands whose relative agonist/antagonist activities vary in a cell- and promoter-dependent manner. The molecular basis underlying this selectivity can be attributed to the ability of these ligands to induce distinct alterations in ER structure leading to differential recruitment of coactivators and corepressors. Whether SERM activity is restricted to synthetic ligands or whether molecules exist in vivo that function in an analogous manner remains unresolved. However, the recent observation that oxysterols bind ER and antagonize the actions of 17β-estradiol (E2) on the vascular wall suggests that this class of ligands may possess SERM activity. We demonstrate here that 27-hydroxycholesterol (27HC), the most prevalent oxysterol in circulation, functions as a SERM, the efficacy of which varies when assessed on different endpoints. Importantly, 27HC positively regulates both gene transcription and cell proliferation in cellular models of breast cancer. Using combinatorial peptide phage display, we have determined that 27HC induces a unique conformational change in both ERα and ERβ, distinguishing it from E2 and other SERMs. Thus, as with other ER ligands, it appears that the unique pharmacological activity of 27HC relates to its ability to impact ER structure and modulate cofactor recruitment. Cumulatively, these data indicate that 27HC is an endogenous SERM with partial agonist activity in breast cancer cells and suggest that it may influence the pathology of breast cancer. Moreover, given the product-precursor relationship between 27HC and cholesterol, our findings have implications with respect to breast cancer risk in obese/hypercholesteremic individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cloning of a novel receptor expressed in rat prostate and ovary.
Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., & Gustafsson, J. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5925 · Cited by 4,788
Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J.-A. (1997) · Endocrinology · doi:10.1210/endo.138.3.4979 · Cited by 4,442
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A
Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J.-M., Argos, P., & Chambon, P. (1986) · Nature · doi:10.1038/320134a0 · Cited by 2,321
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
Heery, D. M., Kalkhoven, E., Hoare, S., & Parker, M. G. (1997) · Nature · doi:10.1038/42750 · Cited by 2,128
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
Paech, K., Webb, P., Kuiper, G. G. J. M., Nilsson, S., Gustafsson, J.-Å., Kushner, P. J., & Scanlan, T. S. (1997) · Science · doi:10.1126/science.277.5331.1508 · Cited by 1,861
An oxysterol signalling pathway mediated by the nuclear receptor LXRα
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., & Mangelsdorf, D. J. (1996) · Nature · doi:10.1038/383728a0 · Cited by 1,591
Self-citationHall, J. M., & McDonnell, D. P. (1999) · Endocrinology · doi:10.1210/endo.140.12.7179 · Cited by 1,075
Self-citationSources of estrogen and their importance
Simpson, E. R. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00360-1 · Cited by 936
Oxysterols and atherosclerosis
Brown, A. J., & Jessup, W. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00196-8 · Cited by 919
Frasor, J., Danes, J. M., Komm, B., Chang, K. C. N., Lyttle, C. R., & Katzenellenbogen, B. S. (2003) · Endocrinology · doi:10.1210/en.2003-0567 · Cited by 876
Webb, P. (1995) · Molecular Endocrinology · doi:10.1210/me.9.4.443 · Cited by 693
Tzukerman, M. T. (1994) · Molecular Endocrinology · doi:10.1210/me.8.1.21 · Cited by 671
The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors
Hu, X., & Lazar, M. A. (1999) · Nature · doi:10.1038/47069 · Cited by 644
Endogenous hormones as a major factor in human cancer.
Henderson, B. E., Ross, R. K., Pike, M. C., & Casagrande, J. T. (1982) · PubMed · Cited by 602
Proteasome-dependent degradation of the human estrogen receptor
Nawaz, Z., Lonard, D. M., Dennis, A. P., Smith, C. L., & O’Malley, B. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.1858 · Cited by 589
Lonard, D. M., Nawaz, Z., Smith, C. L., & O'Malley, B. W. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80259-2 · Cited by 562
Molecular determinants of nuclear receptor-corepressor interaction
Perissi, V., Staszewski, L. M., McInerney, E. M., Kurokawa, R., Krones, A., Rose, D. W., Lambert, M. H., Milburn, M. V., Glass, C. K., & Rosenfeld, M. G. (1999) · Genes & Development · doi:10.1101/gad.13.24.3198 · Cited by 513
Minireview: Aromatase and the Regulation of Estrogen Biosynthesis—Some New Perspectives
Simpson, E. R., & Davis, S. R. (2001) · Endocrinology · doi:10.1210/endo.142.11.8547 · Cited by 505
Abnormal Vascular Function and Hypertension in Mice Deficient in Estrogen Receptor β
Zhu, Y., Bian, Z., Lu, P., Karas, R. H., Bao, L., Cox, D., Hodgin, J., Shaul, P. W., Thorén, P., Smithies, O., et al. (2002) · Science · doi:10.1126/science.1065250 · Cited by 482
Self-citationFunctional Synergy between the Transcription Factor Sp1 and the Estrogen Receptor
Porter, W. W., Saville, B., Hoivik, D. J., & Safe, S. H. (1997) · Molecular Endocrinology · doi:10.1210/me.11.11.1569 · Cited by 428
Wijayaratne, A. L., & McDonnell, D. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101097200 · Cited by 427
Self-citationEstrogen receptor (ER) modulators each induce distinct conformational changes in ER α and ER β
Paige, L. A., Christensen, D. J., Grøn, H., Norris, J. D., Gottlin, E. B., Padilla, K. M., Chang, C.-Y., Ballas, L. M., Hamilton, P. T., McDonnell, D. P., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3999 · Cited by 412
Self-citation27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen
Umetani, M., Domoto, H., Gormley, A. K., Yuhanna, I. S., Cummins, C. L., Javitt, N. B., Korach, K. S., Shaul, P. W., & Mangelsdorf, D. J. (2007) · Nature Medicine · doi:10.1038/nm1641 · Cited by 396
Self-citationTumor-Associated Macrophages: The Double-Edged Sword in Cancer Progression
Chen, J. J. W., Lin, Y.-C., Yao, P.-L., Yuan, A., Chen, H.-Y., Shun, C.-T., Tsai, M.-F., Chen, C.-H., & Yang, P.-C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.172 · Cited by 374
Peptide Antagonists of the Human Estrogen Receptor
Norris, J. D., Paige, L. A., Christensen, D. J., Chang, C.-Y., Huacani, M. R., Fan, D., Hamilton, P. T., Fowlkes, D. M., & McDonnell, D. P. (1999) · Science · doi:10.1126/science.285.5428.744 · Cited by 373
Self-citationEstrogen Receptor-α Mediates the Protective Effects of Estrogen Against Vascular Injury
Pare, G., Krust, A., Karas, R. H., Dupont, S., Aronovitz, M., Chambon, P., & Mendelsohn, M. E. (2002) · Circulation Research · doi:10.1161/01.res.0000021114.92282.fa · Cited by 369
Cali, J. J., & Russell, D. W. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89517-9 · Cited by 368
Chang, C.-Y., Norris, J. D., Grøn, H., Paige, L. A., Hamilton, P. T., Kenan, D. J., Fowlkes, D., & McDonnell, D. P. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8226 · Cited by 364
Self-citationIn vivo imaging of transcriptionally active estrogen receptors
Ciana, P., Raviscioni, M., Mussi, P., Vegeto, E., Que, I., Parker, M. G., Lowik, C., & Maggi, A. (2003) · Nature Medicine · doi:10.1038/nm809 · Cited by 286
Brouchet, L., Krust, A., Dupont, S., Chambon, P., Bayard, F., & Arnal, J. F. (2001) · Circulation · doi:10.1161/01.cir.103.3.423 · Cited by 268
Serum High-Density Lipoprotein Cholesterol, Metabolic Profile, and Breast Cancer Risk
Furberg, A.-S., Veierod, M. B., Wilsgaard, T., Bernstein, L., & Thune, I. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh216 · Cited by 264
Oestrogen receptor knockout mice: roles for oestrogen receptors α and β in reproductive tissues
Hewitt, S. C., & Korach, K. S. (2003) · Reproduction · doi:10.1530/rep.0.1250143 · Cited by 257
Engineering of a Mouse for the in Vivo Profiling of Estrogen Receptor Activity
Ciana, P. (2001) · Molecular Endocrinology · doi:10.1210/me.15.7.1104 · Cited by 182
Zhu, Y., Sullivan, L. L., Nair, S. S., Williams, C. C., Pandey, A. K., Marrero, L., Vadlamudi, R. K., & Jones, F. E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4397 · Cited by 174
Wang, W., Dong, L., Saville, B., & Safe, S. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.8.0323 · Cited by 172
Yu, J. L., & Rak, J. W. (2003) · Breast Cancer Research · doi:10.1186/bcr573 · Cited by 146
Coactivator AIB1 links estrogen receptor transcriptional activity and stability
Shao, W., Keeton, E. K., McDonnell, D. P., & Brown, M. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402997101 · Cited by 146
Self-citationMonocyte–Macrophage System as a Target for Estrogen and Selective Estrogen Receptor Modulators
Härkönen, P. L., & Väänänen, H. K. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1386.045 · Cited by 134
Estrogen receptor α and Sp1 regulate progesterone receptor gene expression
Schultz, J. R., Petz, L. N., & Nardulli, A. M. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00415-x · Cited by 121
Estrogen and Progestin Regulation of Cell Cycle Progression
Sutherland, R. L., Prall, O. W. J., Watts, C. K. W., & Musgrove, E. A. (1998) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018774302092 · Cited by 116
Huang, H.-J., Norris, J. D., & McDonnell, D. P. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0089 · Cited by 114
Self-citationZhao, Y., Agarwal, V. R., Mendelson, C. R., & Simpson, E. R. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80013-1 · Cited by 112
Burkard, I., von Eckardstein, A., Waeber, G., Vollenweider, P., & Rentsch, K. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.09.026 · Cited by 109
Tang, R., Ojeda‐Uribe, M., Pouillart, P., Scholl, S., Beuvon, F., & Mosseri, V. (1992) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240500403 · Cited by 98
Upper abdominal obesity, insulin resistance and breast cancer risk
Stoll, B. A. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801998 · Cited by 96
Development of Peptide Antagonists That Target Estrogen Receptor β-Coactivator Interactions
Hall, J. M., Chang, C., & McDonnell, D. P. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.12.0561 · Cited by 90
Self-citationBrown, A. J., Watts, G. F., Burnett, J. R., Dean, R. T., & Jessup, W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004060200 · Cited by 84
Nagel, S. C., Hagelbarger, J. L., & McDonnell, D. P. (2001) · Endocrinology · doi:10.1210/endo.142.11.8471 · Cited by 82
Self-citationPetz, L. N., Ziegler, Y., Schultz, J. R., & Nardulli, A. M. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0105 · Cited by 81
Flötotto, T., Djahansouzi, S., Gläser, M., Hanstein, B., Niederacher, D., Brumm, C., & Beckmann, M. W. (2001) · Hormone and Metabolic Research · doi:10.1055/s-2001-16936 · Cited by 70
What do we know about the mechanisms of aromatase inhibitor resistance?
Chen, S., Masri, S., Wang, X., Phung, S., Yuan, Y.-C., & Wu, X. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.012 · Cited by 64
Structure and function of the pS2 gene and estrogen receptor in human breast cancer cells
Stack, G., Kumar, V., Green, S., Ponglikitmongkol, M., Berry, M., Rio, M., Nunez, A. M., Roberts, M., Koehl, C., Bellocq, P., et al. (1988) · Cancer treatment and research · doi:10.1007/978-1-4613-1733-3_8 · Cited by 44
Hormone replacement therapy and cardiovascular disease
Rossouw, J. E. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199910000-00007 · Cited by 39
Fritah, A., Redeuilh, G., & Sabbah, M. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.07009 · Cited by 36
Cited by
27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology
Nelson, E. R., Wardell, S. E., Jasper, J. S., Park, S., Suchindran, S., Howe, M. K., Carver, N. J., Pillai, R. V., Sullivan, P. M., Sondhi, V., et al. (2013) · Science · doi:10.1126/science.1241908 · Cited by 839
Self-citationLipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
Butler, L. M., Perone, Y., Dehairs, J., Lupien, L. E., de Laat, V., Talebi, A., Loda, M., Kinlaw, W. B., & Swinnen, J. V. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.013 · Cited by 589
Baek, A. E., Yu, Y.-R. A., He, S., Wardell, S. E., Chang, C.-Y., Kwon, S., Pillai, R. V., McDowell, H. B., Thompson, J. W., Dubois, L. G., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00910-z · Cited by 427
Self-citation27-Hydroxycholesterol Promotes Cell-Autonomous, ER-Positive Breast Cancer Growth
Wu, Q., Ishikawa, T., Sirianni, R., Tang, H., McDonald, J. G., Yuhanna, I. S., Thompson, B., Girard, L., Mineo, C., Brekken, R. A., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.006 · Cited by 358
Self-citationOxysterols: From cholesterol metabolites to key mediators
Mutemberezi, V., Guillemot-Legris, O., & Muccioli, G. G. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.09.002 · Cited by 335
Metadata
- Authors
- DuSell, C. D., Umetani, M., Shaul, P. W., Mangelsdorf, D. J., & McDonnell, D. P.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2008-01-01
- Volume
- 22
- Issue
- 1
- Pages
- 65-77
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- OpenAlex
- W1995424431
- Cited by
- 301
- References
- 54
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.